£132.71

It has never been this cheap. We have no record of a lower price.

£133 today · cheaper than every other day in the last 3 months

Springer Diagnosis and Treatment of Parkinson’s Disease ― State of the Art: 56 (Journal of Neural Transmission. Supplementa, 56)

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 20 days · 20 data points (no recent data)

Historical
Generating forecast…
£132.71 £126.07 £128.73 £131.38 £134.04 £136.69 £139.35 11 August 2026 15 August 2026 20 August 2026 25 August 2026 30 August 2026
View at Amazon ↗

Price data last checked 71 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 20 days • 1 price levels

Days at Price
20 days 0 5 10 15 20 £133 Days at Price

Price Analysis

Most common price: £133 (20 days, 100.0%)

Price range: £133 - £133

Price levels: 1 different prices over 20 days

Description

Expert clinicians and basic scientists with a special interest in Parkinson’s disease review the current state of science and clinical therapeutics of the disease. Therefore these articles represent an authorative review of the current state of knowledge regarding preclinical course and symptomatology, subtypes with their impact on the pathology, genetic alterations, novel mechanisms of neuronal cell death, diagnostic tools and old and novel therapeutic approaches with respect to neuroprotection and neuroregeneration in Parkinson’s disease. Particular emphasis has been placed on a novel antiparkinsonian drug called budipine with various modes of action also influencing altered non dopaminergic systems in Parkinson’s disease. It is evident, that many questions on the cause, course and treatment of Parkinson’s disease are still unanswered and therefore the ideal way to treat a parkinsonian patient remains to be defined.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
11 May 1999
Listed Since
08 December 2006

Barcode

No barcode data available

Similar Products You Might Like

Parkinson's Disease: Current and Future Therapeutics and Clinical Trials
83% match

Parkinson's Disease: Current and Future Therapeutics and Clinical Trials

Cambridge University Press

£94.61 22 Oct 2026
Pharmacological Foundations of Parkinson’s Disease: From Mechanisms to Clinical Practice
81% match

Pharmacological Foundations of Parkinson’s Disease: From Mechanisms to Clinical Practice

Elsevier

£137.99 21 Oct 2026
Malattia di Parkinson e parkinsonismi: La prospettiva delle neuroscienze cognitive
80% match

Malattia di Parkinson e parkinsonismi: La prospettiva delle neuroscienze cognitive

Springer

£61.98 26 Oct 2026
Systems Biology of Parkinson's Disease
80% match

Systems Biology of Parkinson's Disease

Springer

£107.78 22 Oct 2026
Handbook of Non-Motor Symptoms in Parkinson's Disease
79% match

Handbook of Non-Motor Symptoms in Parkinson's Disease

Springer

£39.77 24 Oct 2026
Atypical Parkinsonian Disorders: Clinical and Research Aspects (Current Clinical Neurology)
79% match

Atypical Parkinsonian Disorders: Clinical and Research Aspects (Current Clinical Neurology)

Humana

£62.45 21 Oct 2026
Programmed Cells from Basic Neuroscience to Therapy: 20 (Research and Perspectives in Neurosciences, 20)
79% match

Programmed Cells from Basic Neuroscience to Therapy: 20 (Research and Perspectives in Neurosciences, 20)

Springer

£108.15 30 Oct 2026
Advanced and Integrative Therapeutic Strategies in Parkinson’s Disease Management
78% match

Advanced and Integrative Therapeutic Strategies in Parkinson’s Disease Management

Elsevier

£133.99 22 Oct 2026
Emerging Neurobiology of Antidepressant Treatments: 66 (Current Topics in Behavioral Neurosciences, 66)
78% match

Emerging Neurobiology of Antidepressant Treatments: 66 (Current Topics in Behavioral Neurosciences, 66)

Springer

£154.66 21 Oct 2026
Neuropsychiatric Disorders
78% match

Neuropsychiatric Disorders

Springer

£113.77 23 Oct 2026
Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)
78% match

Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)

Springer

£107.23 04 Nov 2026
Behavioral Neurobiology of Huntington's Disease and Parkinson's Disease: 22 (Current Topics in Behavioral Neurosciences, 22)
77% match

Behavioral Neurobiology of Huntington's Disease and Parkinson's Disease: 22 (Current Topics in Behavioral Neurosciences, 22)

Springer

£76.42 27 Oct 2026
Parkinson’s Disease: Neurophysiological, Clinical, and Related Aspects: 90 (Advances in Experimental Medicine and Biology, 90)
77% match

Parkinson’s Disease: Neurophysiological, Clinical, and Related Aspects: 90 (Advances in Experimental Medicine and Biology, 90)

Springer

£76.42 25 Oct 2026
Neurodegenerative Diseases: 6 (Topics in Medicinal Chemistry, 6)
77% match

Neurodegenerative Diseases: 6 (Topics in Medicinal Chemistry, 6)

Springer

£108.06 23 Oct 2026
Psych Cog Disorders Parkinson Dis
77% match

Psych Cog Disorders Parkinson Dis

Cambridge University Press

£52.48 27 Oct 2026
Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers
77% match

Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers

Springer

£97.49 17 Oct 2026
Nonmotor Parkinson's: The Hidden Face: The Many Hidden Faces (Volume 133) (International Review of Neurobiology, Volume 133)
77% match

Nonmotor Parkinson's: The Hidden Face: The Many Hidden Faces (Volume 133) (International Review of Neurobiology, Volume 133)

Elsevier

£163.99 21 Oct 2026
Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)
77% match

Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)

Springer

£113.03 23 Oct 2026
Leucine-Rich Repeat Kinase 2 (LRRK2): 14 (Advances in Neurobiology, 14)
77% match

Leucine-Rich Repeat Kinase 2 (LRRK2): 14 (Advances in Neurobiology, 14)

Springer

£108.97 22 Oct 2026
Ageing and Dementia: Current And Future Concepts: 62 (Journal of Neural Transmission. Supplementa, 62)
77% match

Ageing and Dementia: Current And Future Concepts: 62 (Journal of Neural Transmission. Supplementa, 62)

Springer

£166.00 24 Oct 2026
Neurodegenerative Disorders: A Clinical Guide
77% match

Neurodegenerative Disorders: A Clinical Guide

Springer

£60.42 23 Oct 2026
Molecular Biology of Neuropsychiatric Disorders: 23 (Nucleic Acids and Molecular Biology, 23)
77% match

Molecular Biology of Neuropsychiatric Disorders: 23 (Nucleic Acids and Molecular Biology, 23)

Springer

£144.94 22 Oct 2026
Psychopharmacology of the Developmental Disabilities (Disorders of Human Learning, Behavior, and Communication)
76% match

Psychopharmacology of the Developmental Disabilities (Disorders of Human Learning, Behavior, and Communication)

Springer

£76.42 24 Oct 2026
Pathogenesis of Neurodegenerative Disorders (Contemporary Neuroscience)
76% match

Pathogenesis of Neurodegenerative Disorders (Contemporary Neuroscience)

Humana

£147.14 22 Oct 2026